CARTAR: a comprehensive web tool for identifying potential targets in chimeric antigen receptor therapies using TCGA and GTEx data
Briefings in Bioinformatics · 2024
DOI: 10.1093/bib/bbae326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2024. Verfasst von Miguel Hernandez-Gamarra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Av. Barcelona, …. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xunta de Galicia.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) therapy has emerged as a ground-breaking advancement in cancer treatment, harnessing the power of engineered human immune cells to target and eliminate cancer cells. The escalating interest and investment in CAR therapy in recent years emphasize its profound significance in clinical research, positioning it as a rapidly expanding frontier in the field of personalized cancer therapies. A crucial step in CAR therapy design is choosing the right target as it determines the therapy’s effectiveness, safety and specificity against cancer cells, while sparing healthy tissues. Herein, we propose a suite of tools for the identification and analysis of potential CAR targets leveraging expression data from The Cancer Genome Atlas and Genotype-Tissue Expression Project, which are implemented in CARTAR website. These tools focus on pinpointing tumor-associated antigens, ensuring target selectivity and assessing specificity to avoid off-tumor toxicities and can be used to rationally designing dual CARs. In addition, candidate target expression can be explored in cancer cell lines using the expression data for the Cancer Cell Line Encyclopedia. To our best knowledge, CARTAR is the first website dedicated to the systematic search of suitable candidate targets for CAR therapy. CARTAR is publicly accessible at https://gmxenomica.github.io/CARTAR/.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomic Medicine Group, Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), University of Santiago de Compostela, Av. Barcelona, 15706 A Coruña, Spain.
- C005, Instituto de Investigación Sanitaria de Santiago (IDIS), Travesía da Choupana, 15706 A Coruña, Spain.
- Fundación Pública Galega de Medicina Xenómica (FPGMX), Travesía da Choupana, 15706 A Coruña, Spain.
- CB06/07/0088, Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Av. Monforte de Lemos, 28029 Madrid, Spain.
Förderung
- Xunta de Galicia
Zitieren
APA
Hernandez-Gamarra, M., Salgado-Roo, A., Dominguez, E., Goiricelaya Seco, E. M., Veiga-Rúa, S., Pedrera-Garbayo, L. F., Carracedo, Á., & Allegue, C. (2024). CARTAR: a comprehensive web tool for identifying potential targets in chimeric antigen receptor therapies using TCGA and GTEx data. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbae326
Vancouver
Hernandez-Gamarra M, Salgado-Roo A, Dominguez E, Goiricelaya Seco EM, Veiga-Rúa S, Pedrera-Garbayo LF, et al. CARTAR: a comprehensive web tool for identifying potential targets in chimeric antigen receptor therapies using TCGA and GTEx data. Briefings in Bioinformatics. 2024. doi:10.1093/bib/bbae326
BibTeX
@article{HernandezGamarra2024,
author = {Hernandez-Gamarra, Miguel and Salgado-Roo, Alba and Dominguez, Eduardo and Goiricelaya Seco, Elena María and Veiga-Rúa, Sara and Pedrera-Garbayo, Lucía F and Carracedo, Ángel and Allegue, Catarina},
title = {CARTAR: a comprehensive web tool for identifying potential targets in chimeric antigen receptor therapies using TCGA and GTEx data},
journal = {Briefings in Bioinformatics},
year = {2024},
doi = {10.1093/bib/bbae326}
}
EUVIMED